Author:
Freedman David O,Wilder-Smith Annika Beate,Wilder-Smith Annelies
Reference7 articles.
1. Vaccine value profile for chikungunya;Flandes;Vaccine,2024
2. Chikungunya: risks for travellers;Simon;J Travel Med,2023
3. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial;Schneider;Lancet,2023
4. Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents;Buerger;Lancet Infect Dis,2024
5. Combined immunogenicity evaluation for a new single-dose live-attenuated chikungunya vaccine;Buerger;J Travel Med,2024